At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
TCS IN THE NEWS
You have these already downloaded
We have sent you a copy of the report to your email again.
By SriJyothsna Yeleswarapu, Aditya Rao, Thomas Joseph, Vangala Govindakrishnan Saipradeep and Rajgopal Srinivasan, TCS
A research paper by TCS experts titled "A pipeline to extract drug-adverse event pairs from multiple data sources" was published in the reputed industry journal BMC Medical Informatics and Decision Making.
Pharmacovigilance aims to uncover and understand harmful side-effects of drugs, termed adverse events (AEs). Although the current process of pharmacovigilance is very systematic, the increasing amount of information available in specialized health-related websites as well as the exponential growth in medical literature presents a unique opportunity to supplement traditional adverse event gathering mechanisms with new-age ones.
The paper presents a semi-automated pipeline to extract associations between drugs and side effects from traditional structured adverse event databases as well as from non-traditional sources such as text from MEDLINE abstracts .
Read the complete paper here.
Whether you are a client, partner, investor, or employee, our promise is to be with you for the long run. Let’s take the first step together.
Connect with us